Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Rodriguez

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Cancer Research|May 31, 2002
An anti-ICAM-2 (CD102) monoclonal antibody induces immune-mediated regressions of transplanted ICAM-2-negative colon carcinomasIgnacio Melero, Izaskun Gabari, Angel L Corbí, et al.
Archives of Toxicology|June 3, 2022
In vivo subchronic effects of ciguatoxin-related compounds, reevaluation of their toxicitySandra Raposo-García, Andrea Boente-Juncal, Mercedes Rodriguez-Vieytes, et al.
Parasites & Vectors|June 9, 2023
Retrospective study of the epidemiological risk and serological diagnosis of human babesiosis in Asturias, Northwestern SpainEstrella Montero, María Folgueras, Mercedes Rodriguez-Pérez, et al.
European Journal of Cancer (Oxford, England : 1990)|September 25, 2020
Phase I/II trial of sequential treatment of nab-paclitaxel in combination with gemcitabine followed by modified FOLFOX chemotherapy in patients with untreated metastatic exocrine pancreatic cancer: Phase I resultsAlfredo Carrato, José María Vieitez, Manuel Benavides, et al.
Cancer Biology & Therapy|June 14, 2013
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatmentFrancesco Pantano, Francesco Maria Guida, Caterina Vivaldi, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|January 10, 2015
Fixed drug urticaria: a report of two patientsJosé Barbarroja-Escudero, Maria-Jose Sanchez-Gonzalez, Mercedes Rodriguez-Rodriguez, et al.
Leukemia & Lymphoma|January 20, 2009
Prolonged idiotypic vaccination against follicular lymphomaSusana Inoges, Ascension Lopez-Diaz de Cerio, Natalia Zabalegui, et al.
Journal of Medical Economics|April 11, 2014
Indirect and non-medical economic burden, quality-of-life, and disabilities of the myelofibrosis disease in SpainEmmanuel Gimenez, Carles Besses, Concepcion Boque, et al.
Plos One|October 22, 2015
Evaluation in a Dog Model of Three Antimicrobial Glassy Coatings: Prevention of Bone Loss around Implants and Microbial AssessmentsRoberto López-Píriz, Eva Solá-Linares, Mercedes Rodriguez-Portugal, et al.
Transfusion|August 18, 2023
Transfusion-transmission of hepatitis E virus through red blood cell transfusion but not through platelet concentrates: A case report from SpainAna María Ojea, Carolina Seco, Pablo Mata, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Cancer Research|May 31, 2002
An anti-ICAM-2 (CD102) monoclonal antibody induces immune-mediated regressions of transplanted ICAM-2-negative colon carcinomasIgnacio Melero, Izaskun Gabari, Angel L Corbí, et al.
Archives of Toxicology|June 3, 2022
In vivo subchronic effects of ciguatoxin-related compounds, reevaluation of their toxicitySandra Raposo-García, Andrea Boente-Juncal, Mercedes Rodriguez-Vieytes, et al.
Parasites & Vectors|June 9, 2023
Retrospective study of the epidemiological risk and serological diagnosis of human babesiosis in Asturias, Northwestern SpainEstrella Montero, María Folgueras, Mercedes Rodriguez-Pérez, et al.
European Journal of Cancer (Oxford, England : 1990)|September 25, 2020
Phase I/II trial of sequential treatment of nab-paclitaxel in combination with gemcitabine followed by modified FOLFOX chemotherapy in patients with untreated metastatic exocrine pancreatic cancer: Phase I resultsAlfredo Carrato, José María Vieitez, Manuel Benavides, et al.
Cancer Biology & Therapy|June 14, 2013
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatmentFrancesco Pantano, Francesco Maria Guida, Caterina Vivaldi, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|January 10, 2015
Fixed drug urticaria: a report of two patientsJosé Barbarroja-Escudero, Maria-Jose Sanchez-Gonzalez, Mercedes Rodriguez-Rodriguez, et al.
Leukemia & Lymphoma|January 20, 2009
Prolonged idiotypic vaccination against follicular lymphomaSusana Inoges, Ascension Lopez-Diaz de Cerio, Natalia Zabalegui, et al.
Journal of Medical Economics|April 11, 2014
Indirect and non-medical economic burden, quality-of-life, and disabilities of the myelofibrosis disease in SpainEmmanuel Gimenez, Carles Besses, Concepcion Boque, et al.
Plos One|October 22, 2015
Evaluation in a Dog Model of Three Antimicrobial Glassy Coatings: Prevention of Bone Loss around Implants and Microbial AssessmentsRoberto López-Píriz, Eva Solá-Linares, Mercedes Rodriguez-Portugal, et al.
Transfusion|August 18, 2023
Transfusion-transmission of hepatitis E virus through red blood cell transfusion but not through platelet concentrates: A case report from SpainAna María Ojea, Carolina Seco, Pablo Mata, et al.
Pageof 10